📰 Abt News
Page 171 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 20, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its price objective reduced by Raymond James from $123.00 to $116.00 in a research report report published on Monday morning, The Fly reports. They currently have an outperform rating on the healthcare product maker’s stock. Several other research analysts have also recently issued reports on the company. Wells […]
April 20, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) issued its quarterly earnings data on Wednesday. The healthcare product maker reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.05, Briefing.com reports. The business had revenue of $9.75 billion for the quarter, compared to analysts’ expectations of $9.64 billion. Abbott Laboratories […]
April 20, 2023
Sepio Capital LP boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 62.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 545,537 shares of the healthcare product maker’s stock after buying an additional 210,562 shares during the […]
April 20, 2023
PRW Wealth Management LLC acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 1,856 shares of the healthcare product maker’s stock, valued at approximately $204,000. Other institutional investors and hedge funds […]
April 20, 2023
Carl P. Sherr & Co. LLC purchased a new stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,996 shares of the healthcare product maker’s stock, valued at approximately $219,000. Several other institutional investors […]
April 20, 2023
XXEC Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,909 shares of the healthcare product maker’s stock after acquiring an additional 188 shares during the period. Abbott Laboratories comprises […]
April 19, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) issued an update on its FY23 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $4.30-4.50 for the period, compared to the consensus earnings per share estimate of $4.39. Abbott Laboratories Stock Performance Shares of Abbott Laboratories stock opened at $104.15 on Wednesday. The firm […]
April 19, 2023
Resources Investment Advisors LLC. increased its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 8.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,020 shares of the healthcare product maker’s stock after acquiring an additional 2,059 shares during the period. Resources […]
April 19, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.30-4.50 for the period, compared to the consensus earnings per share estimate of $4.39. Abbott Laboratories Stock Performance Shares of ABT stock opened at $104.15 on Wednesday. The company has a quick ratio of […]
April 19, 2023
Abbott says its making good progress in recovering market share in its pediatric nutrition business after an issue over baby formula last year.